Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy

C. L. Bekker, E. J. Melis, A. C. G. Egberts, M. L. Bouvy, H. Gardarsdottir, B. J. F. van den Bemt*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)100-105
Number of pages6
JournalResearch in Social & Administrative Pharmacy
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Medication waste
  • Unused medications
  • Therapy discontinuation
  • Health economics
  • RETURNED MEDICINES
  • RHEUMATIC-DISEASES
  • MEDICATIONS
  • ADHERENCE
  • COSTS

Cite this